Browsing by Author Matsumura, N.

Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
Nov-2013An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)Huang, R.Y.-J.; Wong, M.K.; Tan, T.Z.; Kuay, K.T.; C Ng, A.H.; Chung, V.Y.; Chu, Y.-S.; Matsumura, N.; Lai, H.-C.; Lee, Y.F.; Sim, W.-J.; Chai, C.; Pietschmann, E.; Mori, S.; Low, J.J.H.; Choolani, M.; Thiery, J.P. 
Jan-2011Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancerMatsumura, N.; Huang, Z.; Mori, S. ; Baba, T.; Fujii, S.; Konishi, I.; Iversen, E.S.; Berchuck, A.; Murphy, S.K.
Jul-2013Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTan, T.Z.; Miow, Q.H.; Huang, R.Y.-J.; Wong, M.K.; Ye, J.; Lau, J.A.; Wu, M.C. ; Bin Abdul Hadi, L.H.; Soong, R. ; Choolani, M.; Davidson, B.; Nesland, J.M.; Wang, L.-Z. ; Matsumura, N.; Mandai, M.; Konishi, I.; Goh, B.-C.; Chang, J.T.; Thiery, J.P. ; Mori, S. 
2012Histotype-specific copy-number alterations in ovarian cancer.Huang, R.Y ; Gynaecology, National University Hospital, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore; Chen, G.B.; Matsumura, N.; Lai, H.C.; Mori, S.; Li, J.; Wong, M.K.; Konishi, I.; Thiery, J.P.; Goh,
Dec-2010Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profilingMatsumura, N.; Mandai, M.; Okamoto, T.; Yamaguchi, K.; Yamamura, S.; Oura, T.; Baba, T.; Hamanishi, J.; Kang, H.S.; Matsui, S.; Mori, S. ; Murphy, S.K.; Konishi, I.
11-Jan-2012The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancerYamamura, S.; Matsumura, N.; Mandai, M.; Huang, Z.; Oura, T.; Baba, T.; Hamanishi, J.; Yamaguchi, K.; Kang, H.S.; Okamoto, T.; Abiko, K.; Mori, S. ; Murphy, S.K.; Konishi, I.